Does ABROCITINIB Cause Pulmonary embolism? 19 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Pulmonary embolism have been filed in association with ABROCITINIB (CIBINQO). This represents 0.6% of all adverse event reports for ABROCITINIB.
19
Reports of Pulmonary embolism with ABROCITINIB
0.6%
of all ABROCITINIB reports
0
Deaths
13
Hospitalizations
How Dangerous Is Pulmonary embolism From ABROCITINIB?
Of the 19 reports, 13 (68.4%) required hospitalization, and 8 (42.1%) were considered life-threatening.
Is Pulmonary embolism Listed in the Official Label?
Yes, Pulmonary embolism is listed as a known adverse reaction in the official FDA drug label for ABROCITINIB.
What Other Side Effects Does ABROCITINIB Cause?
Drug ineffective (398)
Condition aggravated (316)
Off label use (269)
Therapeutic product effect incomplete (186)
Pruritus (171)
Rash (134)
Nausea (130)
Dermatitis atopic (110)
Headache (85)
Acne (73)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which ABROCITINIB Alternatives Have Lower Pulmonary embolism Risk?
ABROCITINIB vs ACALABRUTINIB
ABROCITINIB vs ACAMPROSATE
ABROCITINIB vs ACARBOSE
ABROCITINIB vs ACCUTANE
ABROCITINIB vs ACEBUTOLOL